GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellSource Co Ltd (TSE:4880) » Definitions » ROA %

CellSource Co (TSE:4880) ROA % : 8.41% (As of Jan. 2024)


View and export this data going back to 2019. Start your Free Trial

What is CellSource Co ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. CellSource Co's annualized Net Income for the quarter that ended in Jan. 2024 was 円576 Mil. CellSource Co's average Total Assets over the quarter that ended in Jan. 2024 was 円6,844 Mil. Therefore, CellSource Co's annualized ROA % for the quarter that ended in Jan. 2024 was 8.41%.

The historical rank and industry rank for CellSource Co's ROA % or its related term are showing as below:

TSE:4880' s ROA % Range Over the Past 10 Years
Min: 13.07   Med: 22.79   Max: 37.76
Current: 15.23

During the past 7 years, CellSource Co's highest ROA % was 37.76%. The lowest was 13.07%. And the median was 22.79%.

TSE:4880's ROA % is ranked better than
96.2% of 1553 companies
in the Biotechnology industry
Industry Median: -34.84 vs TSE:4880: 15.23

CellSource Co ROA % Historical Data

The historical data trend for CellSource Co's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellSource Co ROA % Chart

CellSource Co Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
ROA %
Get a 7-Day Free Trial 15.72 13.07 22.79 25.56 16.08

CellSource Co Quarterly Data
Oct18 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.17 16.82 21.57 16.68 8.41

Competitive Comparison of CellSource Co's ROA %

For the Biotechnology subindustry, CellSource Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellSource Co's ROA % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CellSource Co's ROA % distribution charts can be found below:

* The bar in red indicates where CellSource Co's ROA % falls into.



CellSource Co ROA % Calculation

CellSource Co's annualized ROA % for the fiscal year that ended in Oct. 2023 is calculated as:

ROA %=Net Income (A: Oct. 2023 )/( (Total Assets (A: Oct. 2022 )+Total Assets (A: Oct. 2023 ))/ count )
=923.142/( (4599.68+6879.736)/ 2 )
=923.142/5739.708
=16.08 %

CellSource Co's annualized ROA % for the quarter that ended in Jan. 2024 is calculated as:

ROA %=Net Income (Q: Jan. 2024 )/( (Total Assets (Q: Oct. 2023 )+Total Assets (Q: Jan. 2024 ))/ count )
=575.604/( (6879.736+6807.595)/ 2 )
=575.604/6843.6655
=8.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Jan. 2024) net income data. ROA % is displayed in the 30-year financial page.


CellSource Co  (TSE:4880) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Jan. 2024 )
=Net Income/Total Assets
=575.604/6843.6655
=(Net Income / Revenue)*(Revenue / Total Assets)
=(575.604 / 4694.064)*(4694.064 / 6843.6655)
=Net Margin %*Asset Turnover
=12.26 %*0.6859
=8.41 %

Note: The Net Income data used here is four times the quarterly (Jan. 2024) net income data. The Revenue data used here is four times the quarterly (Jan. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


CellSource Co ROA % Related Terms

Thank you for viewing the detailed overview of CellSource Co's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


CellSource Co (TSE:4880) Business Description

Traded in Other Exchanges
N/A
Address
Shibuya Mitake Building, 2nd Floor, 1-19-5 Shibuya, Shibuya-ku, Tokyo, JPN, 150-0002
CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.

CellSource Co (TSE:4880) Headlines

No Headlines